Olaparib Bracanat 150mg Tablets

Get a Price/Quote

MOQ : 10 Pieces

Olaparib Bracanat 150mg Tablets Specification

Indication
Treatment of ovarian, breast, pancreatic, and prostate cancer

Dosage Form
Tablet

Salt Composition
Olaparib 150mg

Feature
PARP inhibitor for targeted cancer therapy

Ingredients
Olaparib and excipients

Application
Oncology

Physical Color/Texture
Film-coated tablet

Storage Instructions
Store below 30C, away from moisture and light

Shelf Life
24 months

Packaging Size
56 tablets per box

Marketed By
Natco Pharma

Administration Route
Oral

Strength
150 mg

International Availability
Available in Canada, Europe, UK, USA, Australia

Brand Name
Bracanat

Prescription Required
Yes

About Olaparib Bracanat 150mg Tablets

New Release: Experience the remarkable efficacy of Bracanat (Olaparib Bracanat 150mg Tablets), a leading PARP inhibitor engineered for targeted cancer therapy in ovarian, breast, pancreatic, and prostate cancer. Jump on this enlightened pharmaceutical solution, designed as film-coated tablets for oral administration. Each box contains 56 tablets, meticulously packaged to preserve potency. Bracanat, marketed by the eminent Natco Pharma, is internationally available across Canada, Europe, UK, USA, and Australia. Pick yours-prescription required-direct from India's trusted manufacturer, supplier, and trader. Shelf life: 24 months.

Key Benefits and Features

Olaparib Bracanat 150mg Tablets deliver eminent targeted cancer therapy through its PARP inhibitor action. Used as a critical component in advanced ovarian, breast, pancreatic, and prostate cancer treatment, it offers remarkable specificity. Special features include film-coated tablets, 24-month shelf life, and international standards maintained by Natco Pharma. This oral oncology medicine is both effective and convenient, securing a place among today's most enlightened targeted therapies.

Supply, Shipping, and Availability

Bracanat is shipped FOB from India with express and secure shipping options for global buyers. Sample availability supports confident procurement while dedicated exchange policies ensure customer satisfaction. Serving the main domestic market of India, Bracanat is accessible to healthcare providers seeking rapid, reliable delivery on every order. International orders benefit from safe and prompt distribution channels, streamlined to connect with Canada, Europe, UK, USA, and Australia.

FAQ's of Olaparib Bracanat 150mg Tablets:

Q: How should Olaparib Bracanat 150mg Tablets be administered?

A: Bracanat tablets are intended for oral administration and should be taken exactly as prescribed by a qualified healthcare professional. Swallow the tablets whole with water and do not crush or chew them.

Q: What are the main indications for using Bracanat 150mg Tablets?

A: Olaparib Bracanat 150mg Tablets are primarily indicated for the treatment of advanced ovarian, breast, pancreatic, and prostate cancers, as determined by your oncologist.

Q: When should Bracanat be used in cancer therapy?

A: Bracanat is used as part of a targeted therapy regimen, often after other treatments have been attempted or in specific genetic cancer cases. Your healthcare provider will determine the appropriate timing and ensure its suitability for your diagnosis.

Q: Where is Bracanat 150mg internationally available?

A: Bracanat is officially available in Canada, Europe, UK, USA, Australia, and India, ensuring broad access for eligible patients worldwide.

Q: What storage conditions are recommended for Bracanat 150mg Tablets?

A: Store below 30C, away from moisture and light, to preserve the medicine's quality and shelf life, which is 24 months from manufacture.

Q: How does Olaparib Bracanat benefit cancer patients?

A: Bracanat acts as an enlightened PARP inhibitor, selectively targeting cancer cells, which can improve treatment efficacy while minimizing harm to healthy tissues.

Tell us about your requirement